Income StatementBalance SheetCash FlowSegments
Edwards Lifesciences logo

Edwards Lifesciences Income Statement

Revenue, expenses, and profitability over time

Edwards Lifesciences generated $6.3B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $1.1B with a 17.39% net margin. Gross margin stands at 77.87% and operating margin at 21.37%. Diluted EPS is $1.88, which declined 0.7% year-over-year. Based on the Q1 2026 filing.

Total Revenue (TTM)$6.3BGross Profit (TTM)$4.9BOperating Income (TTM)$1.3BNet Income (TTM)$1.1BEps Diluted (TTM)$1.88
Latest FilingQ1 2026
Report Date2026-05-06
Market Cap$46.9B
P/E Ratio42.75
ROE10.72%

Operating Expenses

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other Operating Expense, Net$22.7M$19.1M$21.3M$12.5M$14.3M$14.2M
Legal settlement$12.6M$10.9M$15.5M$90.4M$208.6M$37.1M
Impairment and restructuring—$4.2M$4.2M——$0.0
Research and development$241.8M$254.6M$276.2M$280.7M$267.7M$263.3M
Selling, general and administrative$427.3M$465.7M$502.0M$514.6M$602.9M$522.2M

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income from discontinued operations$39.3M-$7.2M-$4.4M-$2.0M$27.0M$0.0
Net income$385.6M$358.0M$333.2M$291.1M$91.2M$380.7M

Earnings Per Share

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Basic earnings per share$0.65$0.61$0.57$0.50$0.16$0.66
Basic EPS from discontinued operations$0.07$-0.01$-0.01$0.00$0.05$0.00
Diluted earnings per share$0.65$0.61$0.56$0.50$0.16$0.66
Continuing operations (in dollars per share)$0.58$0.62$0.58$0.50$0.11$0.66
Continuing operations (in dollars per share)$0.58$0.62$0.57$0.50$0.12$0.66
Discontinued operations (in dollars per share)$0.07$-0.01$-0.01$0.00$0.04$0.00
Weighted-average shares, basic—586.9M587M584.7M—579.2M
Weighted-average shares, diluted—587.8M587.9M585.7M—580.7M

Operating Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Gross profit$1.1B$1.1B$1.2B$1.2B$1.2B$1.3B
Operating income$271.5M$394.8M$411.2M$307.1M$151.1M$477.6M

Income Before Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income before income taxes$349.3M$433.9M$400.2M$348.4M$90.4M$459.0M

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$32.8M$70.3M$64.3M$56.1M$26.2M$78.3M

Other Income & Expense

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Interest income$30.1M$36.5M———$33.5M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other income, net (Note 6)$33.6M$2.6M-$1.3M$2.7M$3.2M$71.5M
Restructuring charges, separation costs, and other (Note 4)$15.3M$4.8M$4.8M$4.8M$4.8M—

Cost of Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total cost of revenue$183.7M$301.6M$344.4M$345.2M$343.0M$362.6M

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenue$1.4B$1.4B$1.5B$1.6B$1.6B$1.6B